<<< Full experiment listing

PXD026918-2

PXD026918 is an original dataset announced via ProteomeXchange.

Dataset Summary
TitleThe therapeutic mechanism of Dengzhanxixin injection on middle cerebral artery occlusion rats based on proteomics
DescriptionTo explore the therapeutic mechanism, we carried out an Dengzhanxixin injection experiment with a focal brain ischemic deficit rat model and explore the target proteins using TMT-based proteomics. Method are shown as follow: 1. Animals and Grouping: The animal experiments were conducted under the direction of NIH Guidelines for the Care and Use of Laboratory Animals (NIH Publications No. 80-23, revised 1996). The procedures were approved by the Animal Care and Use Committees of Beijing Normal University, China. Adult male Sprague–Dawley rats were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. The animals were allowed to acclimate for 7 d before the experiments. Rats were randomly divided into a sham-operated (sham) group, model group, Dengzhan-treated (Dengzhanxixin injection) group, and EDV-treated (edaravone, EDV) group. Dengzhan (0.36 mL/100 g) or EDV (0.18 mL/100 g) was intravenously injected into rats, the first drug treatments were performed immediately after the middle cerebral artery occlusion (MCAO) surgery, the subsequent ones were continually performed with the interval of 12 h, i.e. twice a day; and the drug treatments lasted for 7 d. The rats in the sham group and the model group were treated with the same volume of saline in the same way. 2. MCAO Surgery: Before surgery, rats were fasted overnight, with free access to water. Animals were anaesthetized with 3.5% chloral hydrate (350 mg/kg body weight, i.p.) and MCAO was performed. Briefly, the right common carotid artery, external carotid and internal carotid were exposed through a midline cut. A nylon filament with a heated rounded tip was inserted into the external carotid artery, and was pulled to the internal carotid artery to occlude the origin of the middle cerebral artery. Model animals were subject to 1.5 h of MCAO, and then to reperfusion achieved by a gentle withdrawal of the occluding thread. Sham-operated animals were subjected to the same procedure, except for the insertion of the filament.
HostingRepositoryiProX
AnnounceDate2021-06-25
AnnouncementXMLSubmission_2023-02-06_19:22:00.533.xml
DigitalObjectIdentifier
ReviewLevelPeer-reviewed dataset
DatasetOriginOriginal dataset
RepositorySupportUnsupported dataset by repository
PrimarySubmitterDongfeng Wei
SpeciesList scientific name: Rattus norvegicus; NCBI TaxID: 10116;
ModificationListiodoacetamide derivatized residue
InstrumentOrbitrap Fusion Lumos
Dataset History
RevisionDatetimeStatusChangeLog Entry
02021-06-24 19:54:56ID requested
12021-06-24 19:55:23announced
22023-02-06 19:22:01announced2023-02-07: Update publication information.
Publication List
An H, Tao W, Liang Y, Li P, Li M, Zhang X, Chen K, Wei D, Xie D, Zhang Z, Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke. Front Pharmacol, 12():712436(2021) [pubmed]
Keyword List
submitter keyword: MCAO rat, Dengzhanxixin injection, brain ischemic core tissue, TMT proteomics, acute ischemic stroke
Contact List
Dongfeng Wei
contact affiliationInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
contact emailweidongfeng@aliyun.com
lab head
Dongfeng Wei
contact affiliationInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
contact emailweidongfeng@aliyun.com
dataset submitter
Full Dataset Link List
iProX dataset URI